FDA Import Refusal 799-5040264-3/21/5 — AstraZeneca Canada Inc.
The FDA refused shipment 799-5040264-3/21/5 from AstraZeneca Canada Inc. (Canada) on Sep 22, 2021. The refused product falls under Drugs and Biologics — ESOMEPRAZOLE MAGNESIUM (ANTI-SECRETORY). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 22, 2021
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62TDB06 ESOMEPRAZOLE MAGNESIUM (ANTI-SECRETORY)
- Charges
- 75